40.000
+0,25%
2026-10-19
Fundamental Analysis
100 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +20001.0% | +6968.6% | 3 / 3 | +570.4% | +4.42 pp | +24.73 pp | +56.3% | 0.38 | 3.93 | 153 | +570,4% | 39,2 | +20.001,0% | 3.93 | 9.26 | −57,6% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 40.000 (close price on 2026-10-19)EPS (TTM): 10.183
Financial charts
1.Revenue & growth
VND bn153Q2/26
1.Revenue & growth
VND bn153Q2/26
2.Profit & growth
VND bn39,0Q2/26
3.Profit mix (Penman)
VND bn126Q2/26
4.Margins & cost structure
%38.6%Q2/26
5.Returns & cash cycle
% · days53.4%Q2/26
6.Earnings quality & cash
VND bn155Q2/26
7.Asset structure
VND bn453Q2/26
8.Funding & debt health
VND bn · times453Q2/26
9.Revenue backlog
VND bn25,7Q2/26
10.Valuation
times · %3,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.586Q2/26
Adjusted EPS growth, latest quarter
200,4× higher
Average adjusted EPS growth, 3 quarters
70,5× higher
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26